Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression

M Aiman Mohtar, Delphine Fessart, Chia Yuh Cai, Syazalina Zahari, Saiful Effendi Syafruddin, Muhammad-Redha Abdullah-Zawawi, Valerie Le Morvan, Said Taouji · 2026

Read Genetic regulatory axis between AGR2 and ESR1 promotes breast cancer progression by M Aiman Mohtar, Delphine Fessart, Chia Yuh Cai, Syazalina Zahari, Saiful Effendi Syafruddin, Muhammad-Redha Abdullah-Zawawi, Valerie Le Morvan, Said Taouji (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0351873.txt.

Description

M. Aiman Mohtar and seven co-authors present this 2026 PLOS One lab study of a protein called AGR2. The protein helps breast cancer cells grow, move, and resist chemotherapy. The team used gene editing to delete AGR2 from breast cancer cells. They measured the fallout on cell behavior. They also tracked thousands of genes switched on or off.

Without AGR2, cells migrated less and invaded less. They were easier to kill with drugs. Gene profiling showed wide changes in signaling, stress response, and adhesion programs. Network analysis placed the estrogen receptor at the center of the disturbed web. That receptor is the classic driver of many breast cancers. Public chromosome data tied the receptor's activity to AGR2's own control region. The authors propose this axis as a future drug target.

Catalog record

CREATORM Aiman Mohtar, Delphine Fessart, Chia Yuh Cai, Syazalina Zahari, Saiful Effendi Syafruddin, Muhammad-Redha Abdullah-Zawawi, Valerie Le Morvan, Said Taouji
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE63815
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0351873

Browse the full library · About the Tower of Babel